Lmr Partners LLP Biogen Inc. Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

A detailed history of Lmr Partners LLP transactions in Biogen Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 8,121 shares of BIIB stock, worth $1.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,121

Previous 6,460 25.71%

Holding current value

$1.21 Million

Previous $1.5 Million 5.14%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$189.07 - $236.8 $314,045 - $393,324	1,661 Added 25.71%	8,121 $1.57 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $1.23 Million - $1.53 Million	6,460 New	6,460 $1.5 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $40.5 Million - $45.8 Million	-160,027 Reduced 91.28%	15,294 $3.93 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $38.5 Million - $44.5 Million	139,878 Added 394.66%	175,321 $49.9 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $9.09 Million - $10.4 Million	35,443 New	35,443 $9.85 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $4.53 Million - $5.71 Million	-23,381 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $713,185 - $916,547	3,185 Added 15.77%	23,381 $5.61 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $738,603 - $963,220	-2,610 Reduced 11.44%	20,196 $5.72 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $2.52 Million - $4.03 Million	9,715 Added 74.21%	22,806 $7.9 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $13.3 Million - $15.5 Million	-54,630 Reduced 80.67%	13,091 $3.66 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $16 Million - $24.1 Million	67,721 New	67,721 $16.6 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $14.1 Million - $17.9 Million	-52,401 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $11.5 Million - $15.9 Million	52,401 New	52,401 $15.5 Million
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $1.03 Million - $1.22 Million	-3,991 Closed	0 $0
Q4 2017 Jan 30, 2018	BUY	$307.64 - $344.58 $1.23 Million - $1.38 Million	3,991	3,991 $1.27 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account